Endocarditis due to Salmonella enterica subsp. arizonae in a patient with sickle cell disease: a case report and review of the literature.
Human cases due to Salmonella enterica subsp. arizonae are especially rare, but it may affect immunocompromised patients and infants. We present a case of endocarditis in a patient with sickle cell disease and a review of earlier cases caused by this rare human pathogen. The patient was successfully treated with ceftriaxone and ciprofloxacin. There are only few cases of salmonella endocarditis reported in the last six decades and it is the first case of Salmonella enterica subsp. arizonae endocarditis in the literature to the best of our knowledge.
Starakis
I
I
Department of Internal Medicine, Patras University Hospital, 26500 Rion-Patras, Greece. istarakis@yahoo.com
Siagris
D
D
Karatza
C
C
Solomou
H
H
Bassaris
H
H
D000755:Anemia, Sickle Cell / Q000150:complications* / Q000175:diagnosis; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D004452:Echocardiography; D004697:Endocarditis, Bacterial / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007677:Kidney Function Tests; D008875:Middle Aged; D012476:Salmonella arizonae
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D002443:Ceftriaxone